These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3693127)

  • 1. Antitumor effect of kazusamycin B on experimental tumors.
    Yoshida E; Komiyama K; Naito K; Watanabe Y; Takamiya K; Okura A; Funaishi K; Kawamura K; Funayama S; Umezawa I
    J Antibiot (Tokyo); 1987 Nov; 40(11):1596-604. PubMed ID: 3693127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kazusamycin B, a novel antitumor antibiotic.
    Funaishi K; Kawamura K; Sugiura Y; Nakahori N; Yoshida E; Okanishi M; Umezawa I; Funayama S; Komiyama K
    J Antibiot (Tokyo); 1987 Jun; 40(6):778-85. PubMed ID: 3610834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of a new antibiotic, kazusamycin.
    Komiyama K; Okada K; Hirokawa Y; Masuda K; Tomisaka S; Umezawa I
    J Antibiot (Tokyo); 1985 Feb; 38(2):224-9. PubMed ID: 3922935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent.
    Schurig JE; Rose WC; Kamei H; Nishiyama Y; Bradner WT; Stringfellow DA
    Invest New Drugs; 1990 Feb; 8(1):7-15. PubMed ID: 2345072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).
    Roberts BJ; Hamelehle KL; Sebolt JS; Leopold WR
    Cancer Chemother Pharmacol; 1986; 16(2):95-101. PubMed ID: 3081269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the new antibiotic kazusamycin and related substances].
    Umezawa I; Komiyama K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):858-64. PubMed ID: 3105461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
    Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
    Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new antitumor antibiotic, kazusamycin.
    Umezawa I; Komiyama K; Oka H; Okada K; Tomisaka S; Miyano T; Takano S
    J Antibiot (Tokyo); 1984 Jul; 37(7):706-11. PubMed ID: 6432763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new antitumor antibiotic, FR-900482. III. Antitumor activity in transplantable experimental tumors.
    Shimomura K; Hirai O; Mizota T; Matsumoto S; Mori J; Shibayama F; Kikuchi H
    J Antibiot (Tokyo); 1987 May; 40(5):600-6. PubMed ID: 3610819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumor effect of a benzoylphenylurea derivative HO-221].
    Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors.
    Canti G; Lattuada D; Morelli S; Nicolin A; Cubeddu R; Taroni P; Valentini G
    Cancer Lett; 1995 Jul; 93(2):255-9. PubMed ID: 7621437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new antitumor antibiotic, FR900840. III. Antitumor activity against experimental tumors.
    Nishimura M; Nakada H; Kawamura I; Mizota T; Shimomura K; Nakahara K; Goto T; Yamaguchi I; Okuhara M
    J Antibiot (Tokyo); 1989 Apr; 42(4):553-7. PubMed ID: 2542208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
    Naoe Y; Inami M; Matsumoto S; Nishigaki F; Tsujimoto S; Kawamura I; Miyayasu K; Manda T; Shimomura K
    Cancer Chemother Pharmacol; 1998; 42(1):31-6. PubMed ID: 9619755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical antitumor activity of bizelesin in mice.
    Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J
    Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
    McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
    Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S; Wang Y; Inoue K; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.